Wataru Okajima

发表

Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, Oncotarget.

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

D. Ichikawa, H. Taniguchi, E. Otsuji, 2017, Scientific Reports.

Prognostic impact of the number of retrieved lymph nodes in patients with gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, Journal of gastroenterology and hepatology.

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, Oncotarget.

Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function

D. Ichikawa, H. Taniguchi, E. Otsuji, 2016, Oncotarget.

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer

D. Ichikawa, H. Taniguchi, E. Otsuji, 2015, British Journal of Cancer.

Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma

D. Ichikawa, H. Taniguchi, E. Otsuji, 2015, Expert opinion on biological therapy.

Plasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma

T Kawaguchi, D. Ichikawa, E. Otsuji, 2014, British Journal of Cancer.

Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2015, Oncotarget.

Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2018, Carcinogenesis.

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, British Journal of Cancer.

Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, American journal of cancer research.

Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, American journal of cancer research.

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids

D. Ichikawa, E. Otsuji, A. Shiozaki, 2017, World journal of gastroenterology.

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, World journal of gastroenterology.

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Oncotarget.

Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.

H. Tsuda, D. Ichikawa, E. Otsuji, 2017, Anticancer research.

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

J. Inazawa, H. Tsuda, I. Imoto, 2014, British Journal of Cancer.

Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers

D. Ichikawa, E. Otsuji, A. Shiozaki, 2016, International journal of molecular sciences.

Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.

H. Tsuda, D. Ichikawa, E. Otsuji, 2016, Anticancer research.